您的位置: 首页 > 农业专利 > 详情页

NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS
专利权人:
Boston Biomedical; Inc.
发明人:
Zhiwei Jiang,Chiang Jia Li,Wei Li,David Leggett
申请号:
US16161413
公开号:
US20190263768A1
申请日:
2018.10.16
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充